Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07501065
PHASE4

Prophylactic Antibiotics for Outpatient Urethral Bulking

Sponsor: University of Miami

View on ClinicalTrials.gov

Summary

The purpose of this study is to evaluate whether taking prophylactic (preventative) antibiotics at the time of standard of care clinic-based urethral bulking reduces the risk of post-procedural urinary tract infection (UTI).

Official title: Prophylactic Antibiotics for Outpatient Urethral Bulking: Impact on Post-Procedural Urinary Tract Infection Rates

Key Details

Gender

FEMALE

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

150

Start Date

2026-06

Completion Date

2028-12

Last Updated

2026-03-30

Healthy Volunteers

No

Interventions

DRUG

Bactrim (800/160 mg) or Macrobid (100mg)

Participants will receive a single oral dose of either Bactrim (800 mg sulfamethoxazole + 160 mg trimethoprim) or if allergic to sulfonamides, a single oral dose of Macrobid (100 mg nitrofurantoin) at the time of the urethral bulking procedure.

Locations (2)

Desai Sethi Urology Institute

Miami, Florida, United States

University of Miami Hospitals and Clinics

Miami, Florida, United States